Prevacid

Prevacid Manufacturers

• Physicians Total Care, Inc.
  

  ×

  Prevacid | Physicians Total Care, Inc.

  

  ---

  PREVACID is available as a capsule and an orally disintegrating tablet, and is available in 15 mg and 30 mg strengths. Directions for use specific to the route and available methods of administration for each of these dosage forms is presented below. PREVACID should be taken before eating. PREVACID products SHOULD NOT BE CRUSHED OR CHEWED. In the clinical trials, antacids were used concomitantly with PREVACID.

  2.1 Recommended Dose Indication Recommended Dose Frequency * Please refer to amoxicillin and clarithromycin full prescribing information for CONTRAINDICATIONS and WARNINGS, and for information regarding dosing in elderly and renally-impaired patients. † Controlled studies did not extend beyond indicated duration. ‡ For patients who do not heal with PREVACID for 8 weeks (5 to 10%), it may be helpful to give an additional 8 weeks of treatment. If there is a recurrence of erosive esophagitis, an additional 8 week course of PREVACID may be considered. § The PREVACID dose was increased (up to 30 mg twice daily) in some pediatric patients after 2 or more weeks of treatment if they remained symptomatic. For pediatric patients unable to swallow an intact capsule please see Administration Options. ¶ Varies with individual patient. Recommended adult starting dose is 60 mg once daily. Doses should be adjusted to individual patient needs and should continue for as long as clinically indicated. Dosages up to 90 mg twice daily have been administered. Daily dose of greater than 120 mg should be administered in divided doses. Some patients with Zollinger-Ellison Syndrome have been treated continuously with PREVACID for more than 4 years. Duodenal Ulcers   Short-Term Treatment 15 mg Once daily for 4 weeks   Maintenance of Healed 15 mg Once daily H. pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence*   Triple Therapy:     PREVACID 30 mg Twice daily (q12h) for 10 or 14 days     Amoxicillin 1 gram Twice daily (q12h) for 10 or 14 days     Clarithromycin 500 mg Twice daily (q12h) for 10 or 14 days   Dual Therapy:     PREVACID 30 mg Three times daily (q8h) for 14 days     Amoxicillin 1 gram Three times daily (q8h) for 14 days Benign Gastric Ulcer   Short-Term Treatment 30 mg Once daily for up to 8 weeks NSAID-associated Gastric Ulcer   Healing 30 mg Once daily for 8 weeks†   Risk Reduction 15 mg Once daily for up to 12 weeks† Gastroesophageal Reflux Disease (GERD)   Short-Term Treatment of Symptomatic GERD 15 mg Once daily for up to 8 weeks   Short-Term Treatment of Erosive Esophagitis 30 mg Once daily for up to 8 weeks‡ Pediatric (1 to 11 years of age)
  Short-Term Treatment of Symptomatic GERD and Short-Term Treatment of Erosive Esophagitis   ≤ 30 kg 15 mg Once daily for up to 12 weeks§   > 30 kg 30 mg Once daily for up to 12 weeks§ (12 to 17 years of age)
  Short-Term Treatment of Symptomatic GERD   Nonerosive GERD 15 mg Once daily for up to 8 weeks   Erosive Esophagitis 30 mg Once daily for up to 8 weeks Maintenance of Healing of Erosive Esophagitis 15 mg Once daily Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome 60 mg Once daily¶ 2.2 Special Populations

  Renal impairment patients and geriatric patients do not require dosage adjustment. However, consider dose adjustment in patients with severe liver impairment [see Use in Specific Populations (8.5, 8.6 and 8.7)].

  2.3 Important Administration Information

  Administration Options

  PREVACID Delayed-Release Capsules - Oral Administration

  PREVACID Delayed-Release Capsules should be swallowed whole. Alternatively, for patients who have difficulty swallowing capsules, PREVACID Delayed-Release Capsules can be opened and administered as follows: Open capsule. Sprinkle intact granules on one tablespoon of either applesauce, ENSURE® pudding, cottage cheese, yogurt or strained pears. Swallow immediately. PREVACID Delayed-Release Capsules may also be emptied into a small volume of either apple juice, orange juice or tomato juice and administered as follows: Open capsule. Sprinkle intact granules into a small volume of either apple juice, orange juice or tomato juice (60 mL – approximately 2 ounces). Mix briefly. Swallow immediately. To ensure complete delivery of the dose, the glass should be rinsed with two or more volumes of juice and the contents swallowed immediately.

  PREVACID Delayed-Release Capsules - Nasogastric Tube (≥16 French) Administration

  For patients who have a nasogastric tube in place, PREVACID Delayed-Release Capsules can be administered as follows: Open capsule. Mix intact granules into 40 mL of apple juice. DO NOT USE OTHER LIQUIDS. Inject through the nasogastric tube into the stomach. Flush with additional apple juice to clear the tube.

  USE IN OTHER FOODS AND LIQUIDS HAS NOT BEEN STUDIED CLINICALLY AND IS THEREFORE NOT RECOMMENDED.

  PREVACID SoluTab™ Delayed-Release Orally Disintegrating Tablets

  PREVACID SoluTab should not be broken or cut. PREVACID SoluTab should not be chewed. Place the tablet on the tongue and allow it to disintegrate, with or without water, until the particles can be swallowed. The tablet typically disintegrates in less than 1 minute. Alternatively, for children or other patients who have difficulty swallowing tablets, PREVACID SoluTab can be delivered in two different ways.
  PREVACID SoluTab – Oral Syringe
  For administration via oral syringe, PREVACID SoluTab can be administered as follows:
  Place a 15 mg tablet in oral syringe and draw up approximately 4 mL of water, or place a 30 mg tablet in oral syringe and draw up approximately 10 mL of water. Shake gently to allow for a quick dispersal. After the tablet has dispersed, administer the contents within 15 minutes. Refill the syringe with approximately 2 mL (5 mL for the 30 mg tablet) of water, shake gently, and administer any remaining contents.
  PREVACID SoluTab – Nasogastric Tube (≥ 8 French) Administration
  For administration via a nasogastric tube, PREVACID SoluTab can be administered as follows: Place a 15 mg tablet in a syringe and draw up 4 mL of water, or place a 30 mg tablet in a syringe and draw up 10 mL of water. Shake gently to allow for a quick dispersal. After the tablet has dispersed, inject through the nasogastric tube into the stomach within 15 minutes. Refill the syringe with approximately 5 mL of water, shake gently, and flush the nasogastric tube.

  Close
  No Recall

  More Info
• Pd-rx Pharmaceuticals, Inc.
  

  ×

  Prevacid | Pd-rx Pharmaceuticals, Inc.

  

  ---

  PREVACID is available as a capsule and an orally disintegrating tablet, and is available in 15 mg and 30 mg strengths. Directions for use specific to the route and available methods of administration for each of these dosage forms is presented below. PREVACID should be taken before eating. PREVACID products SHOULD NOT BE CRUSHED OR CHEWED. In the clinical trials, antacids were used concomitantly with PREVACID.

  2.1 Recommended Dose Indication Recommended Dose Frequency * Please refer to amoxicillin and clarithromycin full prescribing information for CONTRAINDICATIONS and WARNINGS, and for information regarding dosing in elderly and renally-impaired patients. † Controlled studies did not extend beyond indicated duration. ‡ For patients who do not heal with PREVACID for 8 weeks (5 to 10%), it may be helpful to give an additional 8 weeks of treatment. If there is a recurrence of erosive esophagitis, an additional 8 week course of PREVACID may be considered. § The PREVACID dose was increased (up to 30 mg twice daily) in some pediatric patients after 2 or more weeks of treatment if they remained symptomatic. For pediatric patients unable to swallow an intact capsule please see Administration Options. ¶ Varies with individual patient. Recommended adult starting dose is 60 mg once daily. Doses should be adjusted to individual patient needs and should continue for as long as clinically indicated. Dosages up to 90 mg twice daily have been administered. Daily dose of greater than 120 mg should be administered in divided doses. Some patients with Zollinger-Ellison Syndrome have been treated continuously with PREVACID for more than 4 years. Duodenal Ulcers   Short-Term Treatment 15 mg Once daily for 4 weeks   Maintenance of Healed 15 mg Once daily H. pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence*   Triple Therapy:     PREVACID 30 mg Twice daily (q12h) for 10 or 14 days     Amoxicillin 1 gram Twice daily (q12h) for 10 or 14 days     Clarithromycin 500 mg Twice daily (q12h) for 10 or 14 days   Dual Therapy:     PREVACID 30 mg Three times daily (q8h) for 14 days     Amoxicillin 1 gram Three times daily (q8h) for 14 days Benign Gastric Ulcer   Short-Term Treatment 30 mg Once daily for up to 8 weeks NSAID-associated Gastric Ulcer   Healing 30 mg Once daily for 8 weeks†   Risk Reduction 15 mg Once daily for up to 12 weeks† Gastroesophageal Reflux Disease (GERD)   Short-Term Treatment of Symptomatic GERD 15 mg Once daily for up to 8 weeks   Short-Term Treatment of Erosive Esophagitis 30 mg Once daily for up to 8 weeks‡ Pediatric (1 to 11 years of age)
  Short-Term Treatment of Symptomatic GERD and Short-Term Treatment of Erosive Esophagitis   ≤ 30 kg 15 mg Once daily for up to 12 weeks§   > 30 kg 30 mg Once daily for up to 12 weeks§ (12 to 17 years of age)
  Short-Term Treatment of Symptomatic GERD   Nonerosive GERD 15 mg Once daily for up to 8 weeks   Erosive Esophagitis 30 mg Once daily for up to 8 weeks Maintenance of Healing of Erosive Esophagitis 15 mg Once daily Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome 60 mg Once daily¶

  Patients should be instructed that if a dose is missed, it should be taken as soon as possible. However, if the next scheduled dose is due, the patient should not take the missed dose, and should be instructed to take the next dose on time. Patients should be instructed not to take 2 doses at one time to make up for a missed dose.

  2.2 Special Populations

  Renal impairment patients and geriatric patients do not require dosage adjustment. However, consider dose adjustment in patients with severe liver impairment [see Use in Specific Populations (8.5, 8.6 and 8.7)].

  2.3 Important Administration Information

  Administration Options

  PREVACID Delayed-Release Capsules – Oral Administration

  PREVACID Delayed-Release Capsules should be swallowed whole. Alternatively, for patients who have difficulty swallowing capsules, PREVACID Delayed-Release Capsules can be opened and administered as follows: Open capsule. Sprinkle intact granules on one tablespoon of either applesauce, ENSURE pudding, cottage cheese, yogurt or strained pears. Swallow immediately. PREVACID Delayed-Release Capsules may also be emptied into a small volume of either apple juice, orange juice or tomato juice and administered as follows: Open capsule. Sprinkle intact granules into a small volume of either apple juice, orange juice or tomato juice (60 mL – approximately 2 ounces). Mix briefly. Swallow immediately. To ensure complete delivery of the dose, the glass should be rinsed with two or more volumes of juice and the contents swallowed immediately.

  PREVACID Delayed-Release Capsules – Nasogastric Tube (≥16 French) Administration

  For patients who have a nasogastric tube in place, PREVACID Delayed-Release Capsules can be administered as follows: Open capsule. Mix intact granules into 40 mL of apple juice. DO NOT USE OTHER LIQUIDS. Inject through the nasogastric tube into the stomach. Flush with additional apple juice to clear the tube.

  USE IN OTHER FOODS AND LIQUIDS HAS NOT BEEN STUDIED CLINICALLY AND IS THEREFORE NOT RECOMMENDED.

  PREVACID SoluTab Delayed-Release Orally Disintegrating Tablets

  PREVACID SoluTab should not be broken or cut. PREVACID SoluTab should not be chewed. Place the tablet on the tongue and allow it to disintegrate, with or without water, until the particles can be swallowed. The tablet typically disintegrates in less than 1 minute. Alternatively, for children or other patients who have difficulty swallowing tablets, PREVACID SoluTab can be delivered in two different ways.   PREVACID SoluTab – Oral Syringe   For administration via oral syringe, PREVACID SoluTab can be administered as follows: Place a 15 mg tablet in oral syringe and draw up 4 mL of water, or place a 30 mg tablet in oral syringe and draw up 10 mL of water. Shake gently to allow for a quick dispersal. After the tablet has dispersed, administer the contents within 15 minutes. Refill the syringe with approximately 2 mL (5 mL for the 30 mg tablet) of water, shake gently, and administer any remaining contents.   PREVACID SoluTab – Nasogastric Tube (≥8 French) Administration   For administration via a nasogastric tube, PREVACID SoluTab can be administered as follows: Place a 15 mg tablet in a syringe and draw up 4 mL of water, or place a 30 mg tablet in a syringe and draw up 10 mL of water. Shake gently to allow for a quick dispersal. After the tablet has dispersed, inject through the nasogastric tube into the stomach within 15 minutes. Refill the syringe with approximately 5 mL of water, shake gently, and flush the nasogastric tube.

  Close
  No Recall

  More Info
• Lake Erie Medical & Surgical Supply Dba Quality Care Products Llc
  

  ×

  Prevacid | Lake Erie Medical & Surgical Supply Dba Quality Care Products Llc

  

  ---

  PREVACID is available as a capsule and an orally disintegrating tablet, and is available in 15 mg and 30 mg strengths. Directions for use specific to the route and available methods of administration for each of these dosage forms is presented below. PREVACID should be taken before eating. PREVACID products SHOULD NOT BE CRUSHED OR CHEWED. In the clinical trials, antacids were used concomitantly with PREVACID.

  2.1 Recommended Dose Indication Recommended Dose Frequency * Please refer to amoxicillin and clarithromycin full prescribing information for CONTRAINDICATIONS and WARNINGS, and for information regarding dosing in elderly and renally-impaired patients. † Controlled studies did not extend beyond indicated duration. ‡ For patients who do not heal with PREVACID for 8 weeks (5 to 10%), it may be helpful to give an additional 8 weeks of treatment. If there is a recurrence of erosive esophagitis, an additional 8 week course of PREVACID may be considered. § The PREVACID dose was increased (up to 30 mg twice daily) in some pediatric patients after 2 or more weeks of treatment if they remained symptomatic. For pediatric patients unable to swallow an intact capsule please see Administration Options. ¶ Varies with individual patient. Recommended adult starting dose is 60 mg once daily. Doses should be adjusted to individual patient needs and should continue for as long as clinically indicated. Dosages up to 90 mg twice daily have been administered. Daily dose of greater than 120 mg should be administered in divided doses. Some patients with Zollinger-Ellison Syndrome have been treated continuously with PREVACID for more than 4 years. Duodenal Ulcers   Short-Term Treatment 15 mg Once daily for 4 weeks   Maintenance of Healed 15 mg Once daily H. pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence*   Triple Therapy:     PREVACID 30 mg Twice daily (q12h) for 10 or 14 days     Amoxicillin 1 gram Twice daily (q12h) for 10 or 14 days     Clarithromycin 500 mg Twice daily (q12h) for 10 or 14 days   Dual Therapy:     PREVACID 30 mg Three times daily (q8h) for 14 days     Amoxicillin 1 gram Three times daily (q8h) for 14 days Benign Gastric Ulcer   Short-Term Treatment 30 mg Once daily for up to 8 weeks NSAID-associated Gastric Ulcer   Healing 30 mg Once daily for 8 weeks†   Risk Reduction 15 mg Once daily for up to 12 weeks† Gastroesophageal Reflux Disease (GERD)   Short-Term Treatment of Symptomatic GERD 15 mg Once daily for up to 8 weeks   Short-Term Treatment of Erosive Esophagitis 30 mg Once daily for up to 8 weeks‡ Pediatric (1 to 11 years of age)
  Short-Term Treatment of Symptomatic GERD and Short-Term Treatment of Erosive Esophagitis   ≤ 30 kg 15 mg Once daily for up to 12 weeks§   > 30 kg 30 mg Once daily for up to 12 weeks§ (12 to 17 years of age)
  Short-Term Treatment of Symptomatic GERD   Nonerosive GERD 15 mg Once daily for up to 8 weeks   Erosive Esophagitis 30 mg Once daily for up to 8 weeks Maintenance of Healing of Erosive Esophagitis 15 mg Once daily Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome 60 mg Once daily¶

  Patients should be instructed that if a dose is missed, it should be taken as soon as possible. However, if the next scheduled dose is due, the patient should not take the missed dose, and should be instructed to take the next dose on time. Patients should be instructed not to take 2 doses at one time to make up for a missed dose.

  2.2 Special Populations

  Renal impairment patients and geriatric patients do not require dosage adjustment. However, consider dose adjustment in patients with severe liver impairment [see Use in Specific Populations (8.5, 8.6 and 8.7)].

  2.3 Important Administration Information

  Administration Options

  PREVACID Delayed-Release Capsules – Oral Administration

  PREVACID Delayed-Release Capsules should be swallowed whole. Alternatively, for patients who have difficulty swallowing capsules, PREVACID Delayed-Release Capsules can be opened and administered as follows: Open capsule. Sprinkle intact granules on one tablespoon of either applesauce, ENSURE pudding, cottage cheese, yogurt or strained pears. Swallow immediately. PREVACID Delayed-Release Capsules may also be emptied into a small volume of either apple juice, orange juice or tomato juice and administered as follows: Open capsule. Sprinkle intact granules into a small volume of either apple juice, orange juice or tomato juice (60 mL – approximately 2 ounces). Mix briefly. Swallow immediately. To ensure complete delivery of the dose, the glass should be rinsed with two or more volumes of juice and the contents swallowed immediately.

  PREVACID Delayed-Release Capsules – Nasogastric Tube (≥16 French) Administration

  For patients who have a nasogastric tube in place, PREVACID Delayed-Release Capsules can be administered as follows: Open capsule. Mix intact granules into 40 mL of apple juice. DO NOT USE OTHER LIQUIDS. Inject through the nasogastric tube into the stomach. Flush with additional apple juice to clear the tube.

  USE IN OTHER FOODS AND LIQUIDS HAS NOT BEEN STUDIED CLINICALLY AND IS THEREFORE NOT RECOMMENDED.

  PREVACID SoluTab Delayed-Release Orally Disintegrating Tablets

  PREVACID SoluTab should not be broken or cut. PREVACID SoluTab should not be chewed. Place the tablet on the tongue and allow it to disintegrate, with or without water, until the particles can be swallowed. The tablet typically disintegrates in less than 1 minute. Alternatively, for children or other patients who have difficulty swallowing tablets, PREVACID SoluTab can be delivered in two different ways.   PREVACID SoluTab – Oral Syringe   For administration via oral syringe, PREVACID SoluTab can be administered as follows: Place a 15 mg tablet in oral syringe and draw up 4 mL of water, or place a 30 mg tablet in oral syringe and draw up 10 mL of water. Shake gently to allow for a quick dispersal. After the tablet has dispersed, administer the contents within 15 minutes. Refill the syringe with approximately 2 mL (5 mL for the 30 mg tablet) of water, shake gently, and administer any remaining contents.   PREVACID SoluTab – Nasogastric Tube (≥8 French) Administration   For administration via a nasogastric tube, PREVACID SoluTab can be administered as follows: Place a 15 mg tablet in a syringe and draw up 4 mL of water, or place a 30 mg tablet in a syringe and draw up 10 mL of water. Shake gently to allow for a quick dispersal. After the tablet has dispersed, inject through the nasogastric tube into the stomach within 15 minutes. Refill the syringe with approximately 5 mL of water, shake gently, and flush the nasogastric tube.

  Close
  No Recall

  More Info
• Takeda Pharmaceuticals America, Inc.
  

  ×

  Prevacid | Electrolyzed Innovations, Llc

  

  ---

  Wet hands thoroughly with product and allow to dry without wiping.
  

  Close
  No Recall

  More Info
• Bryant Ranch Prepack
  

  ×

  Prevacid | Bryant Ranch Prepack

  

  ---

  PREVACID is available as a capsule and an orally disintegrating tablet, and is available in 15 mg and 30 mg strengths. Directions for use specific to the route and available methods of administration for each of these dosage forms is presented below. PREVACID should be taken before eating. PREVACID products SHOULD NOT BE CRUSHED OR CHEWED. In the clinical trials, antacids were used concomitantly with PREVACID.

  2.1 Recommended Dose Indication Recommended Dose Frequency * Please refer to amoxicillin and clarithromycin full prescribing information for CONTRAINDICATIONS and WARNINGS, and for information regarding dosing in elderly and renally-impaired patients. † Controlled studies did not extend beyond indicated duration. ‡ For patients who do not heal with PREVACID for 8 weeks (5 to 10%), it may be helpful to give an additional 8 weeks of treatment. If there is a recurrence of erosive esophagitis, an additional 8 week course of PREVACID may be considered. § The PREVACID dose was increased (up to 30 mg twice daily) in some pediatric patients after 2 or more weeks of treatment if they remained symptomatic. For pediatric patients unable to swallow an intact capsule please see Administration Options. ¶ Varies with individual patient. Recommended adult starting dose is 60 mg once daily. Doses should be adjusted to individual patient needs and should continue for as long as clinically indicated. Dosages up to 90 mg twice daily have been administered. Daily dose of greater than 120 mg should be administered in divided doses. Some patients with Zollinger-Ellison Syndrome have been treated continuously with PREVACID for more than 4 years. Duodenal Ulcers   Short-Term Treatment 15 mg Once daily for 4 weeks   Maintenance of Healed 15 mg Once daily H. pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence*   Triple Therapy:     PREVACID 30 mg Twice daily (q12h) for 10 or 14 days     Amoxicillin 1 gram Twice daily (q12h) for 10 or 14 days     Clarithromycin 500 mg Twice daily (q12h) for 10 or 14 days   Dual Therapy:     PREVACID 30 mg Three times daily (q8h) for 14 days     Amoxicillin 1 gram Three times daily (q8h) for 14 days Benign Gastric Ulcer   Short-Term Treatment 30 mg Once daily for up to 8 weeks NSAID-associated Gastric Ulcer   Healing 30 mg Once daily for 8 weeks†   Risk Reduction 15 mg Once daily for up to 12 weeks† Gastroesophageal Reflux Disease (GERD)   Short-Term Treatment of Symptomatic GERD 15 mg Once daily for up to 8 weeks   Short-Term Treatment of Erosive Esophagitis 30 mg Once daily for up to 8 weeks‡ Pediatric (1 to 11 years of age)
  Short-Term Treatment of Symptomatic GERD and Short-Term Treatment of Erosive Esophagitis   ≤ 30 kg 15 mg Once daily for up to 12 weeks§   > 30 kg 30 mg Once daily for up to 12 weeks§ (12 to 17 years of age)
  Short-Term Treatment of Symptomatic GERD   Nonerosive GERD 15 mg Once daily for up to 8 weeks   Erosive Esophagitis 30 mg Once daily for up to 8 weeks Maintenance of Healing of Erosive Esophagitis 15 mg Once daily Pathological Hypersecretory Conditions Including
  Zollinger-Ellison Syndrome 60 mg Once daily¶

  Patients should be instructed that if a dose is missed, it should be taken as soon as possible. However, if the next scheduled dose is due, the patient should not take the missed dose, and should be instructed to take the next dose on time. Patients should be instructed not to take 2 doses at one time to make up for a missed dose.

  2.2 Special Populations

  Renal impairment patients and geriatric patients do not require dosage adjustment. However, consider dose adjustment in patients with severe liver impairment [see Use in Specific Populations (8.5, 8.6 and 8.7)].

  2.3 Important Administration Information

  Administration Options

  PREVACID Delayed-Release Capsules – Oral Administration

  PREVACID Delayed-Release Capsules should be swallowed whole. Alternatively, for patients who have difficulty swallowing capsules, PREVACID Delayed-Release Capsules can be opened and administered as follows: Open capsule. Sprinkle intact granules on one tablespoon of either applesauce, ENSURE pudding, cottage cheese, yogurt or strained pears. Swallow immediately. PREVACID Delayed-Release Capsules may also be emptied into a small volume of either apple juice, orange juice or tomato juice and administered as follows: Open capsule. Sprinkle intact granules into a small volume of either apple juice, orange juice or tomato juice (60 mL – approximately 2 ounces). Mix briefly. Swallow immediately. To ensure complete delivery of the dose, the glass should be rinsed with two or more volumes of juice and the contents swallowed immediately.

  PREVACID Delayed-Release Capsules – Nasogastric Tube (≥16 French) Administration

  For patients who have a nasogastric tube in place, PREVACID Delayed-Release Capsules can be administered as follows: Open capsule. Mix intact granules into 40 mL of apple juice. DO NOT USE OTHER LIQUIDS. Inject through the nasogastric tube into the stomach. Flush with additional apple juice to clear the tube.

  USE IN OTHER FOODS AND LIQUIDS HAS NOT BEEN STUDIED CLINICALLY AND IS THEREFORE NOT RECOMMENDED.

  PREVACID SoluTab Delayed-Release Orally Disintegrating Tablets

  PREVACID SoluTab should not be broken or cut. PREVACID SoluTab should not be chewed. Place the tablet on the tongue and allow it to disintegrate, with or without water, until the particles can be swallowed. The tablet typically disintegrates in less than 1 minute. Alternatively, for children or other patients who have difficulty swallowing tablets, PREVACID SoluTab can be delivered in two different ways.   PREVACID SoluTab – Oral Syringe   For administration via oral syringe, PREVACID SoluTab can be administered as follows: Place a 15 mg tablet in oral syringe and draw up 4 mL of water, or place a 30 mg tablet in oral syringe and draw up 10 mL of water. Shake gently to allow for a quick dispersal. After the tablet has dispersed, administer the contents within 15 minutes. Refill the syringe with approximately 2 mL (5 mL for the 30 mg tablet) of water, shake gently, and administer any remaining contents.   PREVACID SoluTab – Nasogastric Tube (≥ 8 French) Administration   For administration via a nasogastric tube, PREVACID SoluTab can be administered as follows: Place a 15 mg tablet in a syringe and draw up 4 mL of water, or place a 30 mg tablet in a syringe and draw up 10 mL of water. Shake gently to allow for a quick dispersal. After the tablet has dispersed, inject through the nasogastric tube into the stomach within 15 minutes. Refill the syringe with approximately 5 mL of water, shake gently, and flush the nasogastric tube.

  Close
  No Recall

  More Info
• Cardinal Health
  

  ×

  Prevacid | Lupin Pharmaceuticals, Inc.

  

  ---

  2.1 Dosage in Adults

  Use the lowest effective dose for the patient. The recommended initial dose is 6.25 mg for women and either 6.25 or 12.5 mg for men, taken only once per night immediately before bedtime with at least 7 to 8 hours remaining before the planned time of awakening. If the 6.25 mg dose is not effective, the dose can be increased to 12.5 mg. In some patients, the higher morning blood levels following use of the 12.5 mg dose increase the risk of next day impairment of driving and other activities that require full alertness [See WARNINGS AND PRECAUTIONS (5.1)]. The total dose of zolpidem tartrate extended-release tablets should not exceed 12.5 mg once daily immediately before bedtime.

  The recommended initial doses for women and men are different because zolpidem clearance is lower in women.

  2.2 Special Populations

  Elderly or debilitated patients may be especially sensitive to the effects of zolpidem tartrate. Patients with hepatic insufficiency do not clear the drug as rapidly as normal subjects. The recommended dose of zolpidem tartrate extended-release tablet USP in both of these patient populations is 6.25 mg once daily immediately before bedtime [See WARNINGS AND PRECAUTIONS (5.1); USE IN SPECIFIC POPULATIONS (8.5)].

  2.3 Use with CNS Depressants

  Dosage adjustment may be necessary when zolpidem tartrate extended-release tablets USP are combined with other CNS depressant drugs because of the potentially additive effects [See WARNINGS AND PRECAUTIONS (5.1)].

  2.4 Administration

  Zolpidem tartrate extended-release tablets USP should be swallowed whole, and not be divided, crushed, or chewed. The effect of zolpidem tartrate extended-release tablets USP may be slowed by ingestion with or immediately after a meal.

  Close
  No Recall

  More Info